BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)
$7.4650
+0.0750 ( +2.97% ) 944.5K
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Market Data
Open
$7.4650
Previous close
$7.3900
Volume
944.5K
Market cap
$1.55B
Day range
$7.2500 - $7.4890
52 week range
$4.0300 - $8.8800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
ars | Annual reports | 1 | Apr 25, 2024 |
def | Proxies and info statements | 20 | Apr 25, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
10-k | Annual reports | 106 | Feb 27, 2024 |
8-k | 8K-related | 16 | Feb 26, 2024 |
8-k | 8K-related | 13 | Jan 18, 2024 |
8-k | 8K-related | 14 | Jan 08, 2024 |
4 | Insider transactions | 1 | Jan 04, 2024 |